Globalspace Technologies has launched a new product ‘PATGPT - A Pharma-specific Large Language Model (LLM) Platform. PATGPT is a ready-to-deploy AI solution designed specifically for pharmaceutical enterprises. It will operate under a hybrid model wherein 50% of the training has been carried out on pharmaceutical datasets by GlobalSpace, and the remaining 50% will be trained using proprietary datasets of pharmaceutical companies within their secure cloud environments.
This approach positions PATGPT both as a product and as a customized LLM training service, enabling pharma companies to securely build organization-specific AI intelligence. In the initial phase, PATGPT will focus on sales, marketing, inventory, and distribution optimization. The future roadmap includes expansion into R&D, clinical trials, pharmacovigilance, and regulatory submissions.
Globalspace Technologies is a Software Product Platform Company with focus on Enterprise Mobility SaaS based solutions, providing integrated software & hardware product platforms and solutions to enable large and medium enterprises embrace mobility & digital technology for their business enhancement.
